News
Rosetta wins European patent covering core element of microRNA technology
Rosetta Genomics has won a European patent covering the use of miR-34a in the preparation of pharmaceuticals used to treat p53-negative cancers. ...
News
Women don’t receive the same treatment as men for heart disease the world-over
Women with acute coronary syndrome (ACS) receive inferior or less aggressive treatment compared to men, according to three large studies presented today at the...
News
Advances in personalized medicine for lung cancer
 Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented...
News
Abbott reports positive levodopa-carbidopa intestinal gel study data
Abbott has announced the Phase 3 study results of its levodopa-carbidopa intestinal gel (LCIG), used for the treatment of advanced Parkinson's Disease (PD). ...
News
VistaGen signs licensing deal for stem cell culture technology
VistaGen Therapeutics has signed a licensing agreement with the McEwen Centre for Regenerative Medicine located at the University Health Network in Toronto, Canada, for...
News
UCLA-engineered stem cells seek out and kill HIV in living organisms
Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now...
News
Takeda to Acquire URL Pharma
Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma - a privately-held pharmaceutical company headquartered in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.